Home News Alkem Laboratories’ arm Enzene Biosciences receives 6 US FDA observations, no data... News Alkem Laboratories’ arm Enzene Biosciences receives 6 US FDA observations, no data integrity issues February 16, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Alkem Laboratories Ltd ended at ₹5,475.55, up by ₹74.00, or 1.37%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR News Goyal urges industry to raise quality standards to achieve $2 trillion export target News PM Narendra Modi to inaugurate Noida International Airport in March, says Yogi Adityanath AI AI startup Emergent scales at record speed by letting anyone build apps on their phone 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Tata Electronics’ Upcoming Fab To Enable Prototype Chip Production For Indian... Uncategorized January 27, 2026 Material Depot raises $10 million to tech-up, expand experience centres, and... News February 9, 2026 Top Stories | $1 trillion global tech rout; Rafale mega deal... AI February 12, 2026 Amit Das on How Think360.ai is Making AI-Driven Lending More Trustworthy,... Uncategorized January 27, 2026 Metro Brands Q3 Results: Profit surges 36% to ₹128 cr on... News January 27, 2026
